The overall aim of Dr. Titulaer’s research is to understand the pathophysiological mechanisms of Autoimmune Encephalitis, and optimize treatment based on a combination of clinical characteristics and immunological profiles. After his MD PhD in Leiden, he moved to Philadelphia, USA as a clinical research fellow (Prof. Dalmau) awarded a Dutch cancer society fellowship, and moved with the laboratory to Barcelona. In 2012 his research “Treatment and prognostic factors for long-term outcome in patients with anti-NMDAR encephalitis” was selected for plenary presentations at both the American Academy of Neurology (AAN) and the American Neurological Association (ANA), and published as a highly referenced paper in Lancet Neurology.

Returning to the Erasmus University Medical Center in Rotterdam, the Netherlands in 2013, he started his own laboratory, in collaboration with Professor Sillevis Smitt, and runs a national referral clinic in Autoimmune Neurology, granted as European Reference Network site.

His research has expanded to large, prospective cohort studies in encephalitis (both children and adults), ‘autoimmune epilepsy’, and ’autoimmune dementia’. He is co-chair of the European task force for treatment guidelines on Autoimmune Encephalitis. He is currently an associate professor and co-chair of the Academic Center for Neuro-inflammatory disorders at Erasmus University Medical Center in Rotterdam, the Netherlands.

Copyright © key4events - All rights reserved